These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16312351)

  • 21. [Pharmacodynamic and pharmacokinetic approaches to optimization of lomefloxacin].
    Iakovlev SV
    Antibiot Khimioter; 1998; 43(10):42-5. PubMed ID: 9825110
    [No Abstract]   [Full Text] [Related]  

  • 22. Vibrio parahaemolyticus chromosomal qnr homologue VPA0095: demonstration by transformation with a mutated gene of its potential to reduce quinolone susceptibility in Escherichia coli.
    Saga T; Kaku M; Onodera Y; Yamachika S; Sato K; Takase H
    Antimicrob Agents Chemother; 2005 May; 49(5):2144-5. PubMed ID: 15855551
    [No Abstract]   [Full Text] [Related]  

  • 23. Lomefloxacin sensitivities.
    Smith JM; Hashmi ZS
    N Z Med J; 1990 Jun; 103(891):277-8. PubMed ID: 2356052
    [No Abstract]   [Full Text] [Related]  

  • 24. Lomefloxacin sensitivities.
    Smith JM; Hashmi ZS
    N Z Med J; 1989 Jul; 102(872):391. PubMed ID: 2797570
    [No Abstract]   [Full Text] [Related]  

  • 25. Isolation of quinolone-resistant Escherichia coli found in major rivers in Korea.
    Jung D; Lee MY; Kim JM; Lee JC; Cho DT; Lee Y
    J Microbiol; 2006 Dec; 44(6):680-4. PubMed ID: 17205049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro susceptibility of mycoplasmas to a new quinolone, BAY Y 3118.
    Renaudin H; Bébéar C
    Drugs; 1995; 49 Suppl 2():243-5. PubMed ID: 8549318
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: analysis of the quinolone resistance acquisition.
    Tavío M; Vila J; Ruiz J; Amicosante G; Franceschini N; Martín-Sánchez AM; de Anta MT
    J Antimicrob Chemother; 2000 Apr; 45(4):521-4. PubMed ID: 10747831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of the new type of aminoglycoside acetyltransferase gene in Enterobacter cloacae isolates].
    Xiong ZZ; Wang P; Wang ZX; Li J
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):422-4. PubMed ID: 18581900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased production of AmpC-type beta-lactamases associated with the development of resistance to quinolones in Citrobacter freundii strains.
    Tavío Pérez MM; Amicosante G; Franceschini N; Vila J; Ruiz J; Oratore A; Martín-Sánchez AM; Jiménez de Anta MT
    Microb Drug Resist; 1999; 5(4):235-40. PubMed ID: 10647079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of resistance to quinolone antimicrobials.
    Smith J
    Chemioterapia; 1987 Jun; 6(2 Suppl):208-9. PubMed ID: 3334558
    [No Abstract]   [Full Text] [Related]  

  • 31. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
    Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
    Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
    [No Abstract]   [Full Text] [Related]  

  • 32. Lomefloxacin (NY-198 or SC 47111): in vitro evaluations of a new fluoroquinolone.
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):1S-105S. PubMed ID: 2791492
    [No Abstract]   [Full Text] [Related]  

  • 33. Preliminary results on the antibacterial and killing activity of lomefloxacin.
    Stefani S; Pellegrino MB; Mezzatesta M; Speciale AM; Caccamo F; Russo G; Nicoletti G
    J Chemother; 1989 Jul; 1(4 Suppl):170-2. PubMed ID: 16312355
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of the antibacterial activity of lomefloxacin with that of other antibiotic/chemotherapeutic agents.
    Cuffini AM; Tullio V; Vaiani G; Carlone NA
    J Chemother; 1989 Jul; 1(4 Suppl):178-81. PubMed ID: 16312358
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of lomefloxacin and sparfloxacin on human platelet aggregation.
    Losasso C; Loffreda A; Angrisani M; Contaldi C; Cazzola M; Rossi F
    J Chemother; 1995 Oct; 7(5):420-3. PubMed ID: 8596124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and characteristics of aac(6')-Ib-cr in AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens: a multicenter study from Korea.
    Kim SY; Park YJ; Yu JK; Kim YS; Han K
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):314-8. PubMed ID: 19216942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging plasmid-mediated quinolone resistance associated with the qnrA gene in Enterobacter cloacae clinical isolates in China.
    Wang CX; Cai PQ; Guo Y; Huang ZM; Mi ZH
    J Hosp Infect; 2006 Jul; 63(3):349-50. PubMed ID: 16713016
    [No Abstract]   [Full Text] [Related]  

  • 38. The antibacterial activity of geranium oil against Gram-negative bacteria isolated from difficult-to-heal wounds.
    Sienkiewicz M; Poznańska-Kurowska K; Kaszuba A; Kowalczyk E
    Burns; 2014 Aug; 40(5):1046-51. PubMed ID: 24290961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbon : nitrogen : phosphorus ratios influence biofilm formation by Enterobacter cloacae and Citrobacter freundii.
    Thompson LJ; Gray V; Lindsay D; von Holy A
    J Appl Microbiol; 2006 Nov; 101(5):1105-13. PubMed ID: 17040234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures.
    Wiegand I; Geiss HK; Mack D; Stürenburg E; Seifert H
    J Clin Microbiol; 2007 Apr; 45(4):1167-74. PubMed ID: 17287329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.